In addition, miR-29a-5p agomir treatment suppressed the increasing expression of GSK3β, FKBP5, and AQP4 in the peri-infarction tissue compared with the ischemia-reperfusion group (p < 0.001), as shown by Western blot analysis. This evidence concerns the gene GSK3B and infarction.